Vivo Capital Surplus Fund VIII, L.P.

Track

Insider profile

Vivo Capital Surplus Fund VIII, L.P.'s trades of Terns Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
411.42
Quantity 24,590
Value US$3,941,361
Transaction date
Proposed sale
Price
346.56
Quantity 53,343
Value US$1,078,693
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-04-03 2024-04-03
PrS Proposed sale
24,590
411.42
US$3,941,361 		24,590 411.42 US$3,941,361
2024-04-01 2024-04-01
PrS Proposed sale
53,343
346.56
US$1,078,693 		53,343 346.56 US$1,078,693